Similar Items: Analysis of Treatment Patterns for Mucosal Melanoma Using Real‐World Data in the SEER‐Medicare–Linked Database
- Trends in metastatic thyroid cancer survival from 1992 to 2022: a SEER database analysis
- Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL
- Temozolomide reconsidered: Real-World evidence in resistant melanoma cases
- Real‐World Evidence of Treatment Patterns, Time to Real‐World Progression, and Overall Survival of Patients With Testicular Germ Cell Tumors Receiving Palliative Chemotherapy in the United States
- Primary tumor size as a prognostic factor in duodenal neuroendocrine neoplasms ≤20 mm: a population-based SEER analysis
- Advances in mucosal injury mechanisms in radiation‐induced esophagitis associated with thoracic radiotherapy